Senseonics Holdings (SENS) Cash from Operations (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.26% |
| Dec 31, 2025 | -13.58% |
| Sep 30, 2025 | -70.68% |
| Jun 30, 2025 | 42.37% |
| Mar 31, 2025 | -12.87% |
| Dec 31, 2024 | 3.84% |
| Sep 30, 2024 | -32.97% |
| Jun 30, 2024 | 45.01% |
| Mar 31, 2024 | -34.48% |
| Dec 31, 2023 | 12.73% |
| Sep 30, 2023 | 4.00% |
| Jun 30, 2023 | 9.39% |
| Mar 31, 2023 | -14.15% |
| Dec 31, 2022 | -19.22% |
| Sep 30, 2022 | -2.83% |
| Jun 30, 2022 | 29.65% |
| Mar 31, 2022 | -70.80% |
| Dec 31, 2021 | 14.89% |
| Sep 30, 2021 | 1.99% |
| Jun 30, 2021 | 12.97% |
| Mar 31, 2021 | -97.11% |
| Dec 31, 2020 | 38.43% |
| Sep 30, 2020 | 19.92% |
| Jun 30, 2020 | 42.41% |
| Mar 31, 2020 | 15.95% |
| Dec 31, 2019 | 3.00% |
| Sep 30, 2019 | 0.20% |
| Jun 30, 2019 | -18.41% |
| Mar 31, 2019 | -27.36% |
| Dec 31, 2018 | 11.43% |
| Sep 30, 2018 | -34.54% |
| Jun 30, 2018 | 3.08% |
| Mar 31, 2018 | -25.85% |
| Dec 31, 2017 | -6.82% |
| Sep 30, 2017 | -21.17% |
| Jun 30, 2017 | -8.34% |
| Mar 31, 2017 | -13.67% |
| Dec 31, 2016 | 1.93% |
| Sep 30, 2016 | -4.76% |
| Jun 30, 2016 | -33.88% |
| Sep 30, 2015 | 99.92% |
| Jun 30, 2015 | -109.60% |
| Mar 31, 2015 | -64,326.52% |
| Dec 31, 2014 | -39.97% |